查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602231

關節內粘稠補充療法市場：按產品、來源、應用和最終用途 - 全球預測 2025-2030

Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年關節內粘稠補充療法市場價值為28.3億美元，預計到2024年將達到30.1億美元，複合年成長率為6.19%，預計到2030年將達到43.2億美元。

關節內粘稠補充療法是一種將透明質酸注射到關節中以緩解疼痛並改善活動能力的醫療程序，主要針對骨關節炎患者。需要關節內粘稠補充療法是因為當傳統治療方法不足時，它可以提供顯著的緩解，並且可以作為手術選擇之前的中間解決方案。它的用途主要用於整形外科治療，特別是膝骨關節炎，但其用途也已擴展到髖關節、踝關節和肩關節。最終用途範圍從醫院和診所到門診手術中心，反映了其在各種醫療保健環境中的適應性。市場成長的主要驅動力是全球人口老化、骨關節炎盛行率上升以及對非手術治療選擇的認知不斷提高。透明質酸配方的技術進步以及對微創手術的日益關注將進一步刺激需求。亞太地區等開拓的新興市場存在機遇，這些地區醫療基礎設施的改善正在促進市場進入。在開發提供卓越功效的更持久的配方和遞送方法方面存在跨領域的機會。然而，關節內粘稠補充療法也存在局限性，包括成本和不一致的報銷政策，以及患者反應變化和來自皮質類固醇和富血小板血漿療法等替代療法的競爭等挑戰。創新和研究應集中在新的遞送平台上，例如緩釋性透明質酸產品和結合發炎藥物以增強治療效果的聯合治療。市場競爭激烈、發展迅速，迫使產業參與者不斷創新，適應不斷變化的監管環境和客戶期望。公司應利用數位管道向醫療保健專業人員和患者宣傳治療的好處並提高採用率。優先考慮以患者為中心的研究和擴大臨床適應症對於未來市場的成功至關重要。

主要市場統計
基準年[2023] 28.3億美元
預測年份 [2024] 30.1億美元
預測年份 [2030] 43.2億美元
複合年成長率（%） 6.19%

市場動態：快速發展的關節內粘稠補充療法市場的關鍵市場洞察

供需的動態交互作用正在改變關節內粘稠補充療法市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 骨關節炎非手術治療的需求不斷成長
    • 飲食習慣改變導致文明病增加
    • 世界人口老化和肥胖症迅速增加
  • 市場限制因素
    • 透明質酸治療的副作用和高成本
  • 市場機會
    • 基於透明質酸的治療方法的開發不斷取得進展
    • 擴大關節內粘稠補充療法在髕骨軟骨病變中的作用
  • 市場挑戰
    • 核准規定嚴格，潤滑鎮痛作用持續時間短

波特五力：引領關節內粘稠補充療法市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解關節內粘稠補充療法市場的外部影響

外部宏觀環境因素在塑造關節內粘稠補充療法市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解關節內粘稠補充療法市場的競爭格局

對關節內粘稠補充療法市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣關節內粘稠補充療法市場供應商的績效評估

FPNV定位矩陣是評估關節內粘稠補充療法市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 骨關節炎非手術治療的需求不斷增加
      • 飲食習慣的改變導致文明病的發生率增加
      • 全球老年人口和肥胖症迅速增加
    • 抑制因素
      • 透明質酸治療的副作用和高成本
    • 機會
      • 基於透明質酸的治療方法的開發不斷取得進展
      • 擴大關節內粘稠補充療法在髕骨軟骨病變中的作用
    • 任務
      • 核准嚴格、潤滑鎮痛持續時間短的監理要求
  • 市場區隔分析
    • 產品：三重注射療法的採用激增，以減輕骨關節炎患者的疼痛並增加活動能力
    • 資料來源：越來越偏好非動物源性透明質酸以消除過敏反應的風險
    • 應用：關節內粘稠補充療法治療膝骨關節炎的不斷發展的應用
    • 最終用途：擴大關節內粘稠補充療法在整形外科診所/門診手術中心（ASC）的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章關節內粘稠補充療法市場：依產品

  • 5次注射
  • 單次注射
  • 3次注射

第7章關節內粘稠補充療法市場：依來源分類

  • 動物
  • 非動物的

第8章關節內粘稠補充療法市場：依應用分類

  • 手骨關節炎
  • 髖骨關節炎
  • 膝骨關節炎

第9章關節內粘稠補充療法市場：依最終用途分類

  • 醫院
  • 整形外科診所/門診手術中心 (ASC)

第10章北美和南美關節內粘稠補充療法市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太關節關節內粘稠補充療法市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲關節內粘稠補充療法市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • KiOmed Pharma 和 Arsylab 宣佈建立戰略合作夥伴關係，在法國促銷和分銷 KioMedinevsone，這是一種治療難治性膝骨關節炎的新療法
    • Anika 的 Shingal 在 3 期試驗中達到主要終點

公司名單

  • Avanos Medical, Inc.
  • Viatris Inc.
  • LG Chem Ltd.
  • Anika Therapeutics, Inc.
  • Quimfa SA
  • Sanofi SA
  • Contipro AS
  • Lifecore Biomedical, LLC
  • Smith & Nephew PLC
  • Bioventus LLC
  • Fidia Farmaceutici SpA
  • Alcon Inc.
  • Seikagaku Corporation
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Ferring BV
  • Zimmer Biomet
  • Regen Lab SA
  • Gentex Pharma, LLC
  • Bausch Health Companies Inc.
  • AbbVie Inc.
  • DePuy Synthes by Johnson & Johnson Services, Inc.
Product Code: MRR-0315DDADCE1F

The Viscosupplementation Market was valued at USD 2.83 billion in 2023, expected to reach USD 3.01 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into joints to alleviate pain and improve mobility, primarily for those with osteoarthritis. The necessity of viscosupplementation arises due to its potential to provide significant relief where conventional therapies may not suffice, acting as an intermediate solution before surgical options. Its application is mainly in orthopedic care, particularly for knee osteoarthritis, although research is expanding its use to hip, ankle, and shoulder joints as well. End-use spans from hospitals and clinics to ambulatory surgical centers, reflecting its adaptability in various healthcare settings. Market growth is chiefly driven by the aging global population, the rising prevalence of osteoarthritis, and increasing awareness of non-surgical treatment alternatives. Technological advancements in hyaluronic acid formulations and the growing focus on minimally invasive procedures further stimulate demand. Opportunities lie in untapped emerging markets like Asia-Pacific, where improving healthcare infrastructure is fostering market entry. There is a cross-sectional opportunity in developing enhanced, longer-lasting formulations and delivery methods that could provide superior efficacy. However, limitations include the cost of viscosupplementation and inconsistent reimbursement policies, while challenges include variability in patient response and competition from alternative treatments like corticosteroids and platelet-rich plasma therapies. Innovation and research should focus on novel delivery platforms, such as sustained-release hyaluronic acid products or combination therapies that incorporate anti-inflammatory agents to enhance treatment outcomes. The market is characterized by strong competition and rapid advancements, thus industry players must continuously innovate and adapt to shifting regulatory scenarios and customer expectations. Companies should leverage digital channels to educate healthcare professionals and patients on treatment benefits to drive adoption. Prioritizing patient-centric research and expanding clinical indications will be crucial for future market success.

KEY MARKET STATISTICS
Base Year [2023] USD 2.83 billion
Estimated Year [2024] USD 3.01 billion
Forecast Year [2030] USD 4.32 billion
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viscosupplementation Market

The Viscosupplementation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Need for Non-Surgical Treatment for Osteoarthritis
    • Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
    • Surge in Geriatric Population and Obesity Globally
  • Market Restraints
    • Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
  • Market Opportunities
    • Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
    • Extending Role of Viscosupplementation in Patellar Chondropathy
  • Market Challenges
    • Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief

Porter's Five Forces: A Strategic Tool for Navigating the Viscosupplementation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viscosupplementation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viscosupplementation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viscosupplementation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viscosupplementation Market

A detailed market share analysis in the Viscosupplementation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viscosupplementation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viscosupplementation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include Avanos Medical, Inc., Viatris Inc., LG Chem Ltd., Anika Therapeutics, Inc., Quimfa S.A., Sanofi S.A., Contipro A.S., Lifecore Biomedical, LLC, Smith & Nephew PLC, Bioventus LLC, Fidia Farmaceutici S.p.A., Alcon Inc., Seikagaku Corporation, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Ferring B.V., Zimmer Biomet, Regen Lab SA, Gentex Pharma, LLC, Bausch Health Companies Inc., AbbVie Inc., and DePuy Synthes by Johnson & Johnson Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Five Injection, Single Injection, and Three Injection.
  • Based on Source, market is studied across Animal and Non-animal.
  • Based on Application, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis.
  • Based on End-use, market is studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
      • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
      • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
      • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
    • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
    • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
    • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Viscosupplementation Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Non-animal

8. Viscosupplementation Market, by Application

  • 8.1. Introduction
  • 8.2. Hand Osteoarthritis
  • 8.3. Hip Osteoarthritis
  • 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viscosupplementation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
    • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

Companies Mentioned

  • 1. Avanos Medical, Inc.
  • 2. Viatris Inc.
  • 3. LG Chem Ltd.
  • 4. Anika Therapeutics, Inc.
  • 5. Quimfa S.A.
  • 6. Sanofi S.A.
  • 7. Contipro A.S.
  • 8. Lifecore Biomedical, LLC
  • 9. Smith & Nephew PLC
  • 10. Bioventus LLC
  • 11. Fidia Farmaceutici S.p.A.
  • 12. Alcon Inc.
  • 13. Seikagaku Corporation
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. Ferring B.V.
  • 17. Zimmer Biomet
  • 18. Regen Lab SA
  • 19. Gentex Pharma, LLC
  • 20. Bausch Health Companies Inc.
  • 21. AbbVie Inc.
  • 22. DePuy Synthes by Johnson & Johnson Services, Inc.

LIST OF FIGURES

  • FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023